Cardiology Drug Update An Issue of Cardiology Clinics 1st Edition by Joanne Foody – Ebook PDF Instant Download/Delivery: 1416062769, 9781416062769
Full download Cardiology Drug Update An Issue of Cardiology Clinics 1st Edition after payment

Product details:
ISBN 10: 1416062769
ISBN 13: 9781416062769
Author: Joanne Foody
Although cardiovascular disease (CVD) mortality rates in the United States have declined in recent years, CVD remains the leading cause of death in both men and women. Each year, nearly 1 million people in the U.S. die from cardiovascular-related conditions. The economic burden—from healthcare costs and lost productivity—is estimated to be between $50 and $100 billion annually.
This challenge is only expected to grow as rates of hypertension, obesity, metabolic syndrome, diabetes, heart failure, and atrial fibrillation continue to rise—especially in an aging global population.
A large number of clinical trials have shown that most cardiovascular events are preventable. Risk factor control—such as managing blood pressure, improving lipid profiles, controlling blood sugar, and intervening in the coagulation system—can prevent first-time or recurrent heart attacks and strokes.
As a result, the field has seen a shift in focus: prevention is now considered a form of intervention. This includes both primary prevention (before symptoms or disease appear) and secondary prevention (after cardiovascular events have occurred).
Cardiology Drug Update An Issue of Cardiology Clinics 1st Table of contents:
-
Angiotensin Receptor Blockers: Novel Role in High‑Risk Patients
-
Renin Inhibitors: Novel Agents for Renoprotection or a Better Angiotensin Receptor Blocker for Blood Pressure Lowering?
-
CETP Inhibitors (Current Therapies Targeting HDL‑c)
-
Extended‑Release Niacin/Laropiprant: Reducing Niacin‑Induced Flushing to Better Realize the Benefit of Niacin in Improving Cardiovascular Risk Factors
-
Levosimendan for Acute Heart Failure
-
Vasopressin Antagonists for Chronic Heart Failure
-
Cardiac Resynchronization Therapy
-
The Pleiotropic Effects of Statins in Heart Failure
-
COX‑2 (Cyclooxygenase‑2) Inhibitors: Pharmacology and Cardiovascular Risk
-
Ranolazine: Mechanism of Action and Efficacy as an Antiarrhythmic Agent
-
Anticoagulants (Unfractionated Heparin, LMWH, Direct Thrombin Inhibitors, Warfarin)
-
Prasugrel: Intensity of Antiplatelet Therapy in Acute Coronary Syndromes
-
People also search for Cardiology Drug Update An Issue of Cardiology Clinics 1st:
cardiology update
cardiology update 2022
updates in cardiology 2021
cardiology updates
cardiology new drugs


